rxstat › Shortages › Allopurinol
Allopurinol shortage status
Partial shortage
Source: Health Canada shortage reports · Updated Jul 9, 2026
Some Allopurinol products are in shortage in Canada (1 of 6 reported products), while others remain available. Your pharmacy may be able to substitute an unaffected manufacturer. The latest estimate for affected products to return is May 29, 2026.
In shortage since
Apr 14, 2026
Est. full return
May 29, 2026
Talk to your pharmacist. Pharmacists can often substitute another manufacturer's version, a different strength, or (in most provinces) adapt or renew a prescription on the spot. Your free provincial health line is 811.
Reports by product
Active shortageAPO-ALLOPURINOL TABLETS
200MG · TABLET · APOTEX INC
DIN 00479799 · since Apr 14, 2026, est. end May 29, 2026 · Disruption of the manufacture of the drug.
ResolvedAPO-ALLOPURINOL TABLETS
300MG · TABLET · APOTEX INC
DIN 00402796 · ended Nov 28, 2024 · Disruption of the manufacture of the drug.
ResolvedZYLOPRIM
300MG · TABLET · AA PHARMA INC
DIN 00402796 · ended Sep 27, 2024 · Disruption of the manufacture of the drug.
ResolvedZYLOPRIM
300MG · TABLET · AA PHARMA INC
DIN 00402796 · ended Sep 27, 2024 · Disruption of the manufacture of the drug.
ResolvedZYLOPRIM
200MG · TABLET · AA PHARMA INC
DIN 00479799 · ended Sep 27, 2024 · Disruption of the manufacture of the drug.
ResolvedZYLOPRIM
200MG · TABLET · AA PHARMA INC
DIN 00479799 · ended Sep 27, 2024 · Disruption of the manufacture of the drug.
ResolvedZYLOPRIM
100MG · TABLET · AA PHARMA INC
DIN 00402818 · ended Sep 27, 2024 · Disruption of the manufacture of the drug.
ResolvedZYLOPRIM
100MG · TABLET · AA PHARMA INC
DIN 00402818 · ended Sep 27, 2024 · Disruption of the manufacture of the drug.
ResolvedAPO-ALLOPURINOL
100MG · TABLET · APOTEX INC
DIN 02402769 · ended Sep 26, 2024 · Disruption of the manufacture of the drug.
ResolvedAPO-ALLOPURINOL
200MG · TABLET · APOTEX INC
DIN 02402777 · ended Sep 26, 2024 · Disruption of the manufacture of the drug.
ResolvedAPO-ALLOPURINOL
200MG · TABLET · APOTEX INC
DIN 02402777 · ended Sep 26, 2024 · Disruption of the manufacture of the drug.
ResolvedAPO-ALLOPURINOL
300MG · TABLET · APOTEX INC
DIN 02402785 · ended Sep 26, 2024 · Disruption of the manufacture of the drug.
Showing 12 of 28 reports. All reports are on file with Health Canada.
What's happening
Allopurinol is currently affected by an active shortage report filed with Health Canada by APOTEX INC.
The reported cause is: disruption of the manufacture of the drug. Manufacturers must report shortages, but end-date estimates are their own projections and often move.
If your usual product is affected, a pharmacist is the fastest route to a solution: they can dispense an unaffected manufacturer's equivalent when one exists, and in most provinces can adapt doses or substitute a therapeutic alternative without a new appointment.
Allopurinol is classified under “ANTIGOUT PREPARATIONS” (ATC M04AA).
Recent changes
Common questions
When will Allopurinol be back in stock in Canada?
The latest manufacturer estimate is May 29, 2026. Estimates are self-reported and often slip; this page updates automatically when they change.
Why is Allopurinol in shortage?
See the reports above; manufacturers must state a reason (most commonly manufacturing disruption or a surge in demand) when filing with Health Canada.
What can my pharmacist do about it?
Often quite a lot: substitute an equivalent product from an unaffected manufacturer, adjust quantities, or in most provinces adapt or renew prescriptions on the spot. Call your pharmacy before visiting, and call 811 for free health advice.
All antigout preparations shortage statuses →
Guides: what to do when your medication is in shortage · how to read shortage reports
Data reflects reports manufacturers are legally required to file with Health Canada, republished with per-drug aggregation by rxstat. Estimated end dates are supplied by manufacturers and frequently change. This page describes drug supply only and is not medical advice; never stop or switch a medication without speaking to your pharmacist or prescriber.